Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors
- DOI
- 10.1136/jitc-2024-010511
- Published
- 2025-02
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2024-010511,
title = {Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors},
author = {Jason J Luke and David J Pinato and Dejan Juric and Patricia LoRusso and Peter J Hosein and Anupam M Desai and Robert Haddad and María de Miguel and Andrés Cervantes and Won Seog Kim and Aurélien Marabelle and Yan Zhang and Yuanxin Rong and Xiaobin Yuan and Stéphane Champiat},
year = {2025},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2024-010511},
url = {https://doi.org/10.1136/jitc-2024-010511}
}RIS
TY - JOUR TI - Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors AU - Jason J Luke AU - David J Pinato AU - Dejan Juric AU - Patricia LoRusso AU - Peter J Hosein AU - Anupam M Desai AU - Robert Haddad AU - María de Miguel AU - Andrés Cervantes AU - Won Seog Kim AU - Aurélien Marabelle AU - Yan Zhang AU - Yuanxin Rong AU - Xiaobin Yuan AU - Stéphane Champiat PY - 2025 JO - Journal for ImmunoTherapy of Cancer DO - 10.1136/jitc-2024-010511 UR - https://doi.org/10.1136/jitc-2024-010511 ER -
APA
Luke, J. J., Pinato, D. J., Juric, D., LoRusso, P., Hosein, P. J., Desai, A. M., Haddad, R., Miguel, M. D., Cervantes, A., Kim, W. S., Marabelle, A., Zhang, Y., Rong, Y., Yuan, X., & Champiat, S. (2025). Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010511
Source records
- crossref · retrieved 2026-09-25T21:41:50.415Z